Simultaneous Quantification of T-Cell Receptor Excision Circles (TRECs) and K-Deleting Recombination Excision Circles (KRECs) by Real-time PCR
December 6th, 2014
16.6K views
Here, we describe a method for simultaneous quantification of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs). The TREC/KREC assay can be used as marker of thymic and bone marrow output.
Overview
This article describes a method for the simultaneous quantification of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs) using a single assay. The TREC/KREC assay serves as a marker for thymic and bone marrow output.
Key Study Components
Area of Science
- Immunology
- Cell Biology
- Molecular Biology
Background
- TRECs and KRECs are important indicators of immune system development.
- Quantifying these markers helps assess thymic and bone marrow function.
- Existing methods often require separate assays for each marker.
- This study addresses the need for a more efficient quantification method.
Purpose of Study
- To develop a method for simultaneous measurement of TRECs and KRECs.
- To analyze thymic and bone marrow output in different age groups.
- To facilitate research in populations with limited blood samples, such as infants.
Methods Used
- Construction of a triple insert plasmid containing TREC and KREC sequences.
- Development of a standard curve through serial dilutions for quantification.
- Real-time PCR assay for absolute quantification of target sequences.
- Analysis of results based on age and gender in healthy individuals.
Main Results
- The method allows for accurate quantification of TRECs and KRECs.
- Results indicate variations in thymic and bone marrow output with age.
- Gender differences in output were also observed.
- The assay is effective for small blood samples, making it suitable for infants.
Conclusions
- The TREC/KREC assay is a valuable tool for immunological studies.
- It provides insights into immune system development across different demographics.
- This method can enhance research in pediatric populations.
Frequently Asked Questions
What are TRECs and KRECs?
TRECs are markers of thymic output, while KRECs indicate bone marrow output.
Why is simultaneous quantification important?
It allows for a more efficient analysis of immune system function without needing multiple assays.
How does age affect TREC and KREC levels?
The study shows that TREC and KREC levels vary with age, reflecting changes in immune system development.
Can this method be used in infants?
Yes, the assay is designed to work with small blood samples, making it suitable for infants.
What is the significance of this research?
It provides a new tool for studying immune function in various populations, particularly in pediatric research.
Executive Industry Relevance
Simultaneous quantification of TRECs and KRECs by real-time PCR enables precise measurement of thymic and bone marrow output, supporting immune monitoring in translational and preclinical research. This duplex assay streamlines workflow efficiency, reduces sample requirements, and enhances predictive confidence for immune reconstitution and deficiency studies. The method is particularly valuable for portfolio decisions involving immune system modulation and hematopoietic interventions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative assessment of lymphocyte production for functional immune system evaluation.
- Supports mechanistic de-risking by distinguishing thymic versus bone marrow contributions.
- Facilitates target validation in studies of immune reconstitution and deficiency.
Screening & Assay Development
- Provides a standardized duplex assay for reproducible quantification of TRECs and KRECs.
- Reduces experimental variability through a single standard curve and reference gene normalization.
- Enables reliable screening of immune-modulating compounds or interventions affecting lymphocyte output.
Translational & Preclinical Research
- Aligns with disease-relevant models for immune deficiency and reconstitution monitoring.
- Supports continuity from discovery through preclinical validation in hematology and immunology pipelines.
- Improves risk-adjusted advancement by providing robust quantitative biomarkers of immune output.
Pipeline & Workflow Integration
This duplex real-time PCR method integrates into the discovery-to-preclinical continuum for immune monitoring, supporting both early mechanistic studies and translational biomarker development.
- Discovery Biology: Quantifies new T and B lymphocyte production to clarify immune pathway function.
- Screening: Delivers reproducible, quantitative outputs for assay standardization and compound evaluation.
- Analytics: Provides absolute quantification and statistical validation of immune cell output.
- Translational Research: Bridges discovery and preclinical studies by enabling immune reconstitution tracking.
- Enterprise Reuse: Offers a scalable, reusable platform for diverse immune monitoring applications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune system assessments and target validation.
- Operational Value: Streamlines workflows, reduces sample and reagent use, and enhances reproducibility.
- Strategic Value: Supports informed go/no-go decisions and reduces late-stage biological risk in immune-focused programs.
- Portfolio Impact: Enables risk-adjusted prioritization of immune modulation and hematopoietic projects.
Implementation Considerations
- Requires expertise in molecular biology and quantitative PCR assay design.
- Needs access to real-time PCR instrumentation and plasmid preparation infrastructure.
- Demands rigorous cross-team standardization for plasmid and standard curve preparation.
- Adaptable to various model systems with appropriate reference gene selection.
- Plasmid construction is time-intensive, but subsequent assays are rapid and scalable.
Biopharma FAQs
Why does null hypothesis testing matter for TREC/KREC quantification?
Null hypothesis testing ensures that observed differences in TREC and KREC levels reflect true biological changes rather than assay variability, supporting robust target validation and immune monitoring decisions.
How does independent variable isolation fit the duplex PCR workflow?
Isolating variables such as age, gender, or disease state allows the duplex PCR assay to attribute changes in TREC and KREC output to specific biological factors, enhancing mechanistic clarity in discovery pipelines.
What do quantitative dependent variable measurements enable in immune studies?
Absolute quantification of TRECs and KRECs enables precise tracking of thymic and bone marrow output, facilitating cross-study comparisons and supporting translational biomarker development.
Why are replication requirements critical for cross-functional immune monitoring?
Replication ensures assay reproducibility and reliability, which is essential for cross-functional teams to confidently interpret immune output data and make portfolio-level decisions.
What statistical analysis capabilities are required before implementing TREC/KREC assays?
Statistical validation of standard curve efficiency, threshold placement, and replicate consistency is required to ensure assay accuracy and support downstream analytical and regulatory needs.
